Dipti K. Pawaskar, Ph.D.
Affiliations: | 2012 | Pharmaceutical Sciences | State University of New York, Buffalo, Buffalo, NY, United States |
Google:
"Dipti Pawaskar"Parents
Sign in to add mentor| William J. Jusko | grad student | 2012 | SUNY Buffalo | |
| (Pharmacokinetic-pharmacodynamic interactions of everolimus and sorafenib in pancreatic cancer.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Pawaskar D, Chen X, Glassman F, et al. (2021) Pharmacokinetic/pharmacodynamic modeling for dose selection for the first-in-human trial of the activated Factor XII inhibitor garadacimab (CSL312). Clinical and Translational Science |
| Pawaskar DK, Straubinger RM, Fetterly GJ, et al. (2013) Synergistic interactions between sorafenib and everolimus in pancreatic cancer xenografts in mice. Cancer Chemotherapy and Pharmacology. 71: 1231-40 |
| Pawaskar DK, Straubinger RM, Fetterly GJ, et al. (2013) Physiologically based pharmacokinetic models for everolimus and sorafenib in mice. Cancer Chemotherapy and Pharmacology. 71: 1219-29 |
| Pawaskar DK, Straubinger RM, Fetterly GJ, et al. (2013) Interactions of everolimus and sorafenib in whole blood lymphocyte proliferation. Pharmaceutical Research. 30: 707-13 |
| Pawaskar DK, Straubinger RM, Fetterly GJ, et al. (2013) Interactions of everolimus and sorafenib in pancreatic cancer cells. The Aaps Journal. 15: 78-84 |
| Pawaskar DK, Straubinger RM, Fetterly G, et al. (2012) Abstract 3681: Multi-scale analysis of everolimus and sorafenib combination in pancreatic cancer xenografts Cancer Research. 72: 3681-3681 |
| Ma W, Weekes C, Pawaskar D, et al. (2012) 584 Preclinical and Clinical Evaluation of the Combination of Sorafenib and Everolimus in Patients with Advanced Solid Tumors European Journal of Cancer. 48: 179 |
| Pawaskar DK, Straubinger R, Fetterly G, et al. (2011) Abstract 27: Physiologically based pharmacokinetic model for interactions of sorafenib and everolimus in mice Cancer Research. 71: 27-27 |
| Woo S, Pawaskar D, Jusko WJ. (2009) Methods of utilizing baseline values for indirect response models. Journal of Pharmacokinetics and Pharmacodynamics. 36: 381-405 |